To gain further insight into PIAS1 binding across the entire EBV genome, we conducted a chromatin immunoprecipitation sequencing (ChIP-seq) experiment using Akata (EBV+) Burkitt lymphoma cells as our model system. This evidence concerns the gene PIAS1 and Burkitt lymphoma.